K. Jørgensen

发表

Comparison of the pharmacological properties of pituitary and biosynthetic human growth hormone. Demonstration of antinatriuretic/antidiuretic and barbital sleep effects of human growth hormone in rats.

K. Jørgensen, 1987, Acta endocrinologica.

Pancreatic Spasmolytic Polypeptide (PSP): II. Radioimmunological determination of PSP in porcine tissues, plasma and pancreatic juice

L. Thim, K. H. Jørgensen, K. Jørgensen, 1982, Regulatory Peptides.

The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-7-carboxamid o)-ethyl)-benzenesulphonyl]-N'-cyclohexlurea (NOVO CS 476). III. General pharmacological studies.

K. Jørgensen, 2009, Acta pharmacologica et toxicologica.

Na(+)-K+ pump in rat muscle: effects of hypophysectomy, growth hormone, and thyroid hormone.

A. Flyvbjerg, S. Marshall, M. Everts, 1990, The American journal of physiology.

Actions of fenfluramine on glucose uptake in vitro and in vivo.

K. Jørgensen, 2009, Acta pharmacologica et toxicologica.

The influence of growth hormone and thyroxine on iodothyronine deiodinase activity in the liver, kidney and brown adipose tissue in hypophysectomized rats.

A. Flyvbjerg, S. Marshall, J. Weeke, 1991, Acta endocrinologica.

Pancreatic Spasmolytic Polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects

L. Thim, K. H. Jørgensen, B. Diamant, 1982, Regulatory Peptides.

Biosynthetic human growth hormone: subchronic toxicity studies in rats and monkeys.

O. Svendsen, R. Greenough, B. Dinesen, 1988, Pharmacology & toxicology.

Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats.

H. Orskov, A. Flyvbjerg, S. Marshall, 1991, The American journal of physiology.

Effects of growth hormone and thyroxine on kidney insulin-like growth factor-I and renal growth in hypophysectomized rats.

H. Orskov, A. Flyvbjerg, S. Marshall, 1993, The Journal of endocrinology.

Growth hormone restores normal growth in selenium-treated rats without increase in circulating somatomedin C.

H. Orskov, A. Flyvbjerg, H. Ørskov, 1988, Acta endocrinologica.

The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo (b) furan-7-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). II. Pharmacological studies on the mechanism of action.

K. Jørgensen, 2009, Acta pharmacologica et toxicologica.

Preclinical studies on human insulin. II. General pharmacological studies.

J. Weis, K. Jørgensen, K. H. Wolffbrandt, 1983, Acta pharmacologica et toxicologica.

Pharmacokinetics of biosynthetic and pituitary human growth hormones in rats.

B. Dinesen, K. Jørgensen, J. D. Monrad, 1988, Pharmacology & toxicology.

Dissociation of the spasmolytic and metabolic effects of glucagon.

J. Weis, B. Diamant, K. Jørgensen, 1983 .

The effects of porcine GIP on insulin secretion and glucose clearance in the pig

A. Moody, K. Jørgensen, K. H. Wolffbrandt, 1983, Regulatory Peptides.

Biosynthetic Human Growth Hormone Identical to Authentic Material

H. H. Sørensen, H. Dalbøge, J. Pedersen, 1986 .

Effect of Human Growth Hormone on the Reproduction of Female Rats

O. Svendsen, K. Jørgensen, K. Skydsgaard, 1991 .

Interaction of human growth hormone and gonadotrophins on the function of rat ovaries.

K. Jørgensen, J. Nowak, 1989, Pharmacology & toxicology.

Effect of growth hormone dosing on ultimate weight and length of XO mice.

H. Orskov, K. Jørgensen, S. Jensen, 1989, Pharmacology & toxicology.